Amethocaine-lidocaine cream, a new topical formulation for preventing venopuncture-induced pain in children

Regional Anesthesia and Pain Medicine

Volumn 27, Issue 3, 2002, Pages 289-295

  Cárceles, María Dolores ^a   Alonso, José María ^a   García Muñoz, Martin ^a   Nájera, María Dolores ^a   Castaño, Isabel ^a   Vila, Nieves ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Amethocaine; EMLA; Lidocaine; Prilocaine; Topical anesthesia

Indexed keywords

EMLA; LIDOCAINE; TETRACAINE; TETRACAINE PLUS LIDOCAINE; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG MIXTURE; FEMALE; HUMAN; INJECTION PAIN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MOTOR ACTIVITY; PAIN ASSESSMENT; PALLOR; PEDIATRIC ANESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TOPICAL ANESTHESIA; VEIN PUNCTURE; VERBALIZATION;

EID: 0036091136     PISSN: 10987339     EISSN: None     Source Type: Journal    
DOI: 10.1053/rapm.2002.30681     Document Type: Article

References (58)

1. Eutectic lidocaine/Prilocaine cream. A review of the topical anaesthetic/analgesic efficacy of a eutectic mixture of local anaesthetics (EMLA)
2. Our experience with EMLA cream (for painless venous cacculation in children)
3. Assessing pain and analgesia with a lidocaine-prilocaine emulsion in infants and toddlers during venopuncture
4. EMLA analgesic cream for venopuncture during anesthetic induction in children
5. Dermal anaesthesia using a eutectic mixture of lidocaine and prilocaine (EMLA) for venopuncture in children
6. Methahemoglobin formation after the use of EMLA cream in term neonates
7. Alleviation of the pain of venopuncture in neonates
8. The influence of stratum corneum morphology on water permeability
9. A linear theory of transdermal transport phenomena
10. Pharmacology of local anaesthetic agents
11. Pharmacokinetics of local anesthetic agents
12. A systematic review of lidocaine-prilocaine cream (EMLA) in the treatment of acute pain in neonates
13. In vivo assessment of percutaneous local anaesthetic preparations
14. Evaluation of amethocaine gel preparation for percutaneous analgesia before venous cannulation in children
15. Comparative topical anaesthesia of EMLA and liposome-encasulated tetracaine
16. Topical anaesthesia of intact skin: Liposome-encapsulated tetracaine vs EMLA
17. Amethocaine gel for percutaneous local anaesthesie
18. Local anesthetics
19. Adverse local reactions to amethocaine cream-audit and case reports
20. Preliminary study to assay plasma amethocaine concentration after topical application of a new local anaesthetic cream containing amethocaine
21. Concentration-response analysis of percutaneous local anaesthetic formulations
22. Testing the validity of an objective pain scale for infants and children
23. Pediatric pain management
24. Assessment and measurement of pain in children
25. Formulación de un gel de tetracaina para anestesia cutanea por Vía Tópica
26. Analysis of medicinals
27. Preformulation
28. Somatization at 4 1/2 years of age in preterm children and control as a function of family factors, mothers-child interaction, child temperement and pain sensivity at 3 years of age
29. A multicentre randomized study of single-unit dose package of EMLA patch vs EMLA 5% cream for venopuncture in children
30. Analgesia for venous cannulation: A comparison of EMLA (5 minutes application), lignocaine, ethyl chloride and nothing
31. Combination of EMLA cream and nitrous oxide for venous cannulation in children
32. Alleviation of the pain of venopuncture in neonates
33. Preoperative preparation and premedication
34. Euptetic versus directive preparation of children for needles
35. Pediatric regional anesthesia
36. Age differences in drug binding by plasma proteins: Studies on human features, neonates and adults
37. R
38. Signs of methaemoglobinemia after topical application of EMLA cream in a infant with haemangioma
39. Prolonged seizures associated with the use of viscous lidocaine
40. Plasma cholinesterase activity in new-borns and infants
41. Pediatric regional anesthesia
42. A risk-benefit assessment of topical percutaneous local anaesthetics in children
43. Contact allegy and cross-reactions caused by prilocaine
44. Anestesia regional pediátrica
45. Toxicity of local anesthetics in infants and children
46. EMLA cream: An improved local anesthetic. A review of current literature
47. EMLA: A new topical anesthetic
48. Safety of lidocaine-prilocaine cream in the treatment of preterm neonates
49. EMLA cream does not cause methaemoglobinemia in the neonate
50. Randomized controlled trial of eutectic mixture of local anaesthetics cream for venopuncture in healthy preterm infants
51. Safety of lidocaine-prilocaine cream application four times a day in premature neonates: A pilot study
52. Does EMLA reduce the discomfort associated with local anaestethic infiltration?
53. Methaemoglobinemia in children treated with prilocaine-lignocaine cream
54. Inverse relationship between age-dependent erytrocyte activity of methaemoglobin reductase and prilocaine-induced methaemoglobinemia during infancy
55. Comparison of skin anesthetic effect of liposomal lidocaine, nonliposomal lidocaine and EMLA using 30 minute application time
56. Cutaneous tape stripping to accelerate the anesthetic effects of EMLA cream: A randomized controlled trial
57. Dermal patch anaesthesia: Comparison of 10% lignocaine gel with absorption promoter and EMLA cream
58. Vascular response of human skin after analgesia with EMLA cream